Net Income (Loss) Attributable to Parent in USD of BICYCLE THERAPEUTICS PLC from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bicycle Therapeutics Plc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2017 to Q3 2025.
  • Bicycle Therapeutics Plc Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$59.1M, a 16.3% decline year-over-year.
  • Bicycle Therapeutics Plc Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$251M, a 50.7% decline year-over-year.
  • Bicycle Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2024 was -$169M, a 6.44% increase from 2023.
  • Bicycle Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2023 was -$181M, a 60.3% decline from 2022.
  • Bicycle Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2022 was -$113M, a 68.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

BICYCLE THERAPEUTICS PLC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$251M -$59.1M -$8.3M -16.3% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$242M -$79M -$39.1M -98.3% 01 Apr 2025 30 Jun 2025 10-Q 30 Oct 2025
Q1 2025 -$203M -$60.8M -$34.2M -129% 01 Jan 2025 31 Mar 2025 10-Q 30 Oct 2025
Q4 2024 -$169M -$51.9M -$2.76M -5.61% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2025
Q3 2024 -$166M -$50.8M -$904K -1.81% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 -$165M -$39.8M +$2.79M +6.55% 01 Apr 2024 30 Jun 2024 10-Q 30 Oct 2025
Q1 2024 -$168M -$26.6M +$12.5M +32% 01 Jan 2024 31 Mar 2024 10-Q 30 Oct 2025
Q4 2023 -$181M -$49.1M -$19.1M -63.8% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 -$162M -$49.9M -$21.6M -76% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 -$140M -$42.6M -$15.8M -58.8% 01 Apr 2023 30 Jun 2023 10-Q 31 Oct 2024
Q1 2023 -$124M -$39.1M -$11.5M -41.7% 01 Jan 2023 31 Mar 2023 10-Q 31 Oct 2024
Q4 2022 -$113M -$30M -$11.9M -66.2% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025
Q3 2022 -$101M -$28.3M -$13.7M -93.1% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 -$87.1M -$26.8M -$8.92M -49.8% 01 Apr 2022 30 Jun 2022 10-Q 02 Nov 2023
Q1 2022 -$78.2M -$27.6M -$11.4M -70.2% 01 Jan 2022 31 Mar 2022 10-Q 02 Nov 2023
Q4 2021 -$66.8M -$18M -$604K -3.47% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 -$66.2M -$14.7M -$4.54M -44.8% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 -$61.7M -$17.9M -$5.8M -47.9% 01 Apr 2021 30 Jun 2021 10-Q 03 Nov 2022
Q1 2021 -$55.9M -$16.2M -$4.87M -43% 01 Jan 2021 31 Mar 2021 10-Q 03 Nov 2022
Q4 2020 -$51M -$17.4M -$13M -296% 01 Oct 2020 31 Dec 2020 10-K 11 Mar 2021
Q3 2020 -$38M -$10.1M -$656K -6.92% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$37.3M -$12.1M -$1.9M -18.6% 01 Apr 2020 30 Jun 2020 10-Q 04 Nov 2021
Q1 2020 -$35.4M -$11.3M -$4.82M -74.1% 01 Jan 2020 31 Mar 2020 10-Q 04 Nov 2021
Q4 2019 -$30.6M -$4.41M +$2.24M +33.7% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 -$32.8M -$9.48M -$1.79M -23.3% 01 Jul 2019 30 Sep 2019 10-K 11 Mar 2021
Q2 2019 -$31.1M -$10.2M -$5.24M -105% 01 Apr 2019 30 Jun 2019 10-K 11 Mar 2021
Q1 2019 -$25.8M -$6.5M -$3.97M -157% 01 Jan 2019 31 Mar 2019 10-K 11 Mar 2021
Q4 2018 -$21.8M -$6.64M 01 Oct 2018 31 Dec 2018 10-K 10 Mar 2020
Q3 2018 -$7.69M 01 Jul 2018 30 Sep 2018 10-K 10 Mar 2020
Q2 2018 -$4.98M 01 Apr 2018 30 Jun 2018 10-K 10 Mar 2020
Q1 2018 -$2.53M 01 Jan 2018 31 Mar 2018 10-K 10 Mar 2020

BICYCLE THERAPEUTICS PLC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$169M +$11.6M +6.44% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2025
2023 -$181M -$67.9M -60.3% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025
2022 -$113M -$45.9M -68.7% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025
2021 -$66.8M -$15.8M -31% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 -$51M -$20.4M -66.7% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 -$30.6M -$8.76M -40.1% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 -$21.8M -$5.59M -34.4% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021
2017 -$16.3M 01 Jan 2017 31 Dec 2017 10-K 10 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.